Shackleford’s HB 1065 advances to governor’s desk

On March 18, State Rep. Robin Shackleford’s (D-Indianapolis) House Bill (HB) 1065 passed the Indiana Senate with a unanimous vote of 49-0. The bill is a significant step forward in providing financial relief to individuals and families participating in cancer clinical trials, helping to alleviate the burdens of travel, lodging, and other incidental costs associated with participation.

Shackleford released the following statement on the bill’s advancement:

“I am incredibly grateful to all my Senate sponsors for their support for this critical legislation, and to State Sen. Charbonneau and State Sen. Jackson for presenting it before the Senate. Their partnership has been instrumental in advancing this important cause.

“This bill creates a tangible solution to the financial challenges faced by many individuals and families engaged in cancer clinical trials. These trials are vital for advancing medical research and developing more effective treatments. However, the associated costs—such as travel, lodging, and other out-of-pocket expenses—often create additional barriers for patients, potentially preventing them from accessing life-saving care and participating in critical research.

“No one should have to worry about how they will pay for a hotel room or gas money while they’re fighting cancer. Their sole focus should be on their health, on healing, and on overcoming this disease. This legislation ensures that financial strain does not become an additional burden during such a challenging time.

“I am proud to have authored this legislation, and I can only imagine how much it will help those who need it most. This is a win not just for patients, but for the future of cancer treatment in Indiana.”

HB 1065 now moves to Governor Braun’s desk for final approval. Once signed into law, the bill will provide much-needed support to those participating in cancer clinical trials, allowing them to focus on what matters most: their health and their future.